Phase 2 Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel With Lapatinib in Stage II/III Her2Neu+ Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Metastatic Breast Cancer
Interventions: DRUG: Lapatinib|DRUG: Doxorubicin|DRUG: Cyclophosphamide|DRUG: Docetaxel|DRUG: Pegfilgrastim|DRUG: Filgrastim|DRUG: Dexamethasone|DRUG: Trastuzumab
Sponsor: George Albert Fisher
Collaborators: GlaxoSmithKline|Sanofi